Atlas Trials

A Study of Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation

Clinical trial NCT05148299 · COMPLETED

Trial details

NCT number
NCT05148299
Sponsor
Swedish Orphan Biovitrum
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Transplant-Associated Thrombotic Microangiopathy
Start date
2022-02-01
Primary completion
2024-12-08
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.